Parametric Portfolio Associates’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Parametric Portfolio Associates’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,307	Closed	-$44K	–	4008
2019 Q2	$44K	Sell	3,307 -4,457	-57%	-$67.3K	﹤0.01%	3916
2019 Q1	$135K	Buy	7,764 +1,874	+32%	+$27.9K	﹤0.01%	3776
2018 Q4	$81K	Buy	+5,890	New	+$104K	﹤0.01%	3804
2017 Q4	–	Sell	-6,012	Closed	-$551K	–	3954
2017 Q3	$551K	Buy	6,012 +2,904	+93%	+$223K	﹤0.01%	3367
2017 Q2	$206K	Buy	3,108 +551	+22%	+$68.2K	﹤0.01%	3795
2017 Q1	$555K	Buy	+2,557	New	+$365K	﹤0.01%	3149
2015 Q4	–	Sell	-948	Closed	-$306K	–	3992
2015 Q3	$306K	Buy	948 +396	+72%	+$174K	﹤0.01%	2953
2015 Q2	$220K	Buy	+552	New	+$235K	﹤0.01%	3727

Other funds holding LUMO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

RCM

Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Parametric Portfolio Associates's LUMO Position: Q3 2019 in Review

Parametric Portfolio Associates sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2019, closing a stake of 3,307 shares — an estimated $44K sold.

Parametric Portfolio Associates first reported a position in LUMO in Q2 2015 and held it in 8 quarters. The position peaked at $555K in Q1 2017. 68 funds tracked by Wall St. Rank hold LUMO as of Q3 2019.

Parametric Portfolio Associates reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Parametric Portfolio Associates sold 3,307 Lumos Pharma, Inc. Common Stock shares in Q3 2019, an estimated $44K.
Parametric Portfolio Associates first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 8 quarters.
Parametric Portfolio Associates's Lumos Pharma, Inc. Common Stock position peaked at $555K in Q1 2017.
68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2019.

Based on Parametric Portfolio Associates's 13F filing for Q3 2019, filed 15 Nov 2019.